Biomet Hip Implants

The M2a Magnum is a hip replacement device manufactured by Biomet, Inc., an orthopedic company with its corporate headquarters in Warsaw, Indiana. The Magnum hip was approved in 2004 by the FDA, through the widely criticized expedited procedure known as the 510(K) process. It has been sold throughout the US and is considered a metal on metal (MoM) hip, consisting of a cobalt-chromium-molybdenum (CoCrMo) metal cup and CoCrMo metal femoral head.

According to Biomet, the Magnum hip holds a significantly lower revision rate when compared to other MoM implants. Biomet further touts the Magnum hip as having lower levels of cobalt ion levels when compared to other MoM hips, and claims the Magnum demonstrates a high survivorship rate at three years post surgery. However, recent reviews and findings concerning Magnum Biomet hip implants paint an entirely different story.

The Perils of Metal on Metal Hip Replacements:

Despite Biomet claiming the Magnum hip is a success, this device remains a metal on metal hip replacement device. These relatively new types of hip replacements are the subject of increasing scrutiny both in the US and abroad, as a vast majority of MoM patients are now reporting serious complaints and the need for revision surgeries. The following complaints are now all too common amongst those who have had a MoM hip replacement, including those with a Magnum Hip:

  • Unexplained Hip Pain
  • Popping/grinding noises
  • Swelling and inflammation of tissue surrounding the implant
  • Soft tissue reaction to metal debris (Metallosis)
  • Elevated levels of chromium and cobalt, as a result of the friction of metal components (Metallosis)
  • Loosening and dislocation of the implant
  • Difficulty walking
  • Bone Fractures
  • Premature hip failure, and the need for revision surgery

As a result of the rising number of complaints, multiple agencies and medical journals worldwide have recently issued advisories concerning MoM hips. In February of 2012, the British Medical Journal advised that all patients with this type of implant should be monitored annually for signs of metallosis. A study by the National Joint Registry for England and Wales, published in March 2012 in The Lancet medical journal, recommended the discontinuation entirely of the use of these types of hip replacements. This was followed by Health Canada issuing a national warning in May of 2012 concerning serious complications associated with metal on metal hips. In the summer of 2012 the FDA convened with an expert panel to further evaluate the dangers of these hips.

Legal Assistance for those with a Magnum Hip:

From 2000-2011, the FDA reportedly received nearly 17,000 reports of adverse events from metal-on-metal hips. With respect to the Magnum hip in particular, there has been a recent rise in adverse events reports to the FDA. During 2009, the FDA reportedly received a mere eleven adverse event reports related to the Magnum hip. However, during 2011 the number of adverse event reports rose to eighty. The total number of adverse event reports related to the Magnum is now reportedly in the mid 400's thus far in 2012.

Call Us At 858-480-6182

Since the public often underreports adverse events to the FDA, it is anticipated that an even greater amount of people have suffered from the harmful effects of the Biomet Hip Implants. If you have experienced any of the complications mentioned above as a result of a MoM or Magnum hip, we welcome you to contact our team at O'Mara and Padilla for a prompt, free legal consultation. All patients who have received a MoM hip are advised to schedule an annual check- up with their physician, regardless of whether one is currently experiencing symptoms or not. Due to the fact that there are legal time limitations which can bar the pursuit of personal injury claims, please do not hesitate to contact O'Mara and Padilla today.